Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
14.57
-0.06 (-0.41%)
Mar 9, 2026, 2:04 PM EDT - Market open

Fulgent Genetics Revenue

In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth. Fulgent Genetics had revenue of $83.34M in the quarter ending December 31, 2025, with 9.34% growth.

Revenue (ttm)
$322.67M
Revenue Growth
+13.83%
P/S Ratio
1.40
Revenue / Employee
$245,377
Employees
1,315
Market Cap
455.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025322.67M39.20M13.83%
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
NeoGenomics727.33M
OPKO Health606.88M
CareDx379.81M
Castle Biosciences344.23M
MDxHealth107.88M
Prenetics Global92.39M
Biodesix88.50M
Revenue Rankings